Cazal 0,5 mg/g + 1,0 mg/g mast
| Name | Cazal 0,5 mg/g + 1,0 mg/g mast |
|---|---|
| Marketing Authorisation Number | HR-H-200221669 |
| Active Substance | betametazondipropionat gentamicinsulfat |
| Composition | Jedan gram masti sadrži 0,5 mg betametazona (u obliku 0,64 mg betametazondipropionata) i 1 mg gentamicina (u obliku 1,67 mg gentamicinsulfata). |
| Pharmaceutical Form | Mast |
| Manufacturer | mibe GmbH Arzneimittel, Brehna, Njemačka |
| Marketing Authorisation Holder | Mibe Pharmaceuticals d.o.o., Zavrtnica 17, Zagreb, Hrvatska |
| Marketing Authorisation Date | 20.07.2021 |
| MA Period of Validity | 20.07.2026 |
| Classification Number | UP/I-530-09/18-01/47 |
| Registration Number | 381-12-01/38-21-03 |
| Prescription | na recept |
| Type of prescription | neponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | D07CC01 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
